Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 27, 2026
Nucor (NUE) Prepares for Q2 2026 Earnings with Guidance Above Consensus on Steel Rebound

Nucor (NUE) Prepares for Q2 2026 Earnings with Guidance Above Consensus on Steel Rebound

Key Takeaways

  • Nucor (NUE) is scheduled to release its second-quarter 2026 results after the market closes on Monday, July 27, with a conference call to follow on Tuesday morning.
  • Company-issued guidance points to GAAP (Generally Accepted Accounting Principles) earnings per share of $4.70 to $4.80, well above analyst consensus estimates near $4.57 to $4.63.
  • All three operating segments — steel mills, steel products, and raw materials — are expected to post sequential earnings growth, with the steel mills segment leading the way.
  • Management's forecast includes a roughly $0.20 per share non-cash benefit tied to the increased valuation of its investment in Helion, a fusion energy company.
  • Nucor has returned approximately $630 million to shareholders through buybacks and dividends year-to-date as of mid-June, underscoring its capital-return commitment.
  • A rebound in benchmark hot-rolled coil (HRC) steel prices toward $1,200 per short ton is a central catalyst behind the expected earnings surge.

Earnings Context and Why It Matters

Nucor Corporation, North America's largest steel producer and recycler, enters its second-quarter 2026 earnings report at a pivotal moment for the domestic steel industry. After HRC prices slumped below $800 per short ton in late summer 2025, a sustained recovery driven by tighter supply, mill price increases, extended lead times, and tariff-reduced imports has pushed prices sharply higher. This rebound comes as Nucor continues to lean on its electric arc furnace (EAF)-based production model, which offers cost flexibility compared to traditional blast furnace operations. With shares climbing roughly 96% over the past year, investor expectations are elevated. The report will test whether the pricing recovery can translate into earnings that meet or exceed both the company's own bullish guidance and Wall Street's upwardly revised estimates. I also checked this setup using Tickeron’s AI Screener to see how Nucor stacks up against peers in the steel sector.

Breaking Down Earnings Expectations

Nucor provided a clear roadmap on June 17, guiding to second-quarter GAAP earnings per share (EPS) of $4.70 to $4.80. Excluding an approximate $0.20 per share non-cash benefit from its Helion investment, adjusted EPS is expected to land between $4.50 and $4.60. That compares to EPS of $3.23 in the first quarter of 2026 and $2.60 in the second quarter of 2025. Analyst consensus estimates, as compiled by Zacks and other services, cluster around $4.57 to $4.63 per share, meaning Nucor's own forecast sits comfortably above the Street. Revenue consensus stands near $9.87 billion, which would represent a roughly 16.7% year-over-year increase.

The steel mills segment is expected to deliver the largest sequential gain, benefiting from higher average selling prices, stable volumes, and approximately $130 million in cash refunds tied to prior-period raw materials procurement costs — a tailwind that will directly reduce cost of goods sold. The steel products segment anticipates higher volumes and slightly improved pricing, while the raw materials division should see gains from stronger realized prices. On the capital-return front, Nucor repurchased approximately 1.12 million shares at an average price of $223.47 during the quarter and returned roughly $630 million to stockholders through buybacks and dividends year-to-date through mid-June. When reviewing the segment contributions, Tickeron’s AI Trend Prediction Engine helped me cross-check historical patterns in steel pricing cycles.

Market Reaction and Investor Sentiment

Investor sentiment heading into Nucor's second-quarter report appears broadly constructive, buoyed by the company's mid-June guidance raise that lifted EPS expectations above consensus. NUE shares have rallied roughly 96% over the trailing twelve months, reflecting optimism around steel pricing and operational execution. However, the strong run-up also raises the bar: with the stock pricing in a significant earnings recovery, any disappointment — whether in revenue, margins, or forward commentary — could trigger a sharper-than-usual negative reaction. On the flip side, Nucor's track record of beating consensus estimates in two of the last four quarters (with an average earnings surprise of approximately 8.1%) suggests the company has the operational momentum to deliver. Key risk factors include potential softening in residential construction, weakness in heavy equipment and agriculture end markets, and uncertainty around the sustainability of steel pricing gains heading into the second half of the year.

Forward Outlook and Key Factors to Monitor

Beyond the headline numbers, investors will closely parse management's commentary on the conference call for signals about the remainder of 2026. Several interconnected themes deserve attention.

First, the trajectory of steel prices remains the single most important variable. HRC prices near $1,200 per short ton have been a powerful earnings driver, but the market will want to know whether Nucor sees these levels as sustainable. Any indication of softening demand from key end markets — including non-residential construction, automotive, and energy — could temper forward expectations even if the second-quarter print is strong.

Second, cost dynamics will be under scrutiny. The $130 million in raw material cash refunds that benefited the steel mills segment in the second quarter is a one-time tailwind. Investors should assess whether underlying cost structures are improving enough to sustain margin expansion absent such non-recurring items. Scrap metal prices, energy costs, and labor availability all factor into this equation.

Third, Nucor's capital allocation strategy continues to draw attention. With $630 million returned to shareholders through mid-June, the pace of buybacks and dividends signals management's confidence in cash flow generation. Any update to the capital-return framework or commentary on M&A (mergers and acquisitions) appetite will be noteworthy.

Finally, the broader macroeconomic environment — including Federal Reserve interest rate policy, infrastructure spending trends, and trade policy developments — will shape the backdrop for steel demand in the quarters ahead. Nucor's diversified end-market exposure provides some insulation, but no steelmaker is immune to a cyclical slowdown.

Enhancing My Research with Tickeron AI Tools

In my own process for preparing for earnings seasons like this one, I’ve found Tickeron’s AI Screener particularly useful for quickly filtering stocks by industry metrics, volatility, and AI signals. It helps surface comparable names and technical setups without hours of manual work, giving a clearer view of where Nucor fits in the broader market. This kind of tool keeps the focus on data-driven insights rather than noise.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NUE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


NUE in upward trend: price rose above 50-day moving average on July 23, 2026

NUE moved above its 50-day moving average on July 23, 2026 date and that indicates a change from a downward trend to an upward trend. In of 26 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 14, 2026. You may want to consider a long position or call options on NUE as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUE just turned positive on July 15, 2026. Looking at past instances where NUE's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for NUE crossed bullishly above the 50-day moving average on July 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUE advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 302 cases where NUE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUE broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. NUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.802) is normal, around the industry mean (2.448). P/E Ratio (21.708) is within average values for comparable stocks, (102.190). NUE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.018). Dividend Yield (0.008) settles around the average of (0.021) among similar stocks. P/S Ratio (1.729) is also within normal values, averaging (2.094).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Nucor Corp (NYSE:NUE), ArcelorMittal (NYSE:MT), Cleveland-Cliffs (NYSE:CLF).

Industry description

The steel industry includes manufacturers of steel and steel-related products. Companies use iron ore and scrap steel to produce steel. The industry also includes companies involved in mining and marketing of steel products. Along with serving some of the domestic markets, U.S. steel output has, over the years, been used by international economies as well. Competition from imported steel has also increased over time. The industry could be susceptible to business cycles, since the element is an important input in industrial production. Some of the globally-renowned steel behemoths include Nucor Corporation, Vale, and ArcelorMittal SA.

Market Cap

The average market capitalization across the Steel Industry is 11.06B. The market cap for tickers in the group ranges from 39.16K to 61.95B. NUE holds the highest valuation in this group at 61.95B. The lowest valued company is ADTC at 39.16K.

High and low price notable news

The average weekly price growth across all stocks in the Steel Industry was -1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 0%. FRD experienced the highest price growth at 12%, while INHD experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Steel Industry was -89%. For the same stocks of the Industry, the average monthly volume growth was -89% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 30
Price Growth Rating: 47
SMR Rating: 79
Profit Risk Rating: 67
Seasonality Score: -45 (-100 ... +100)
View a ticker or compare two or three
NUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of steel and steel products

Industry Steel

Profile
Details
Industry
Steel
Address
1915 Rexford Road
Phone
+1 704 366-7000
Employees
32000
Web
https://www.nucor.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.